South & Central America Drug Discovery Informatics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow (Discovery Informatics and Drug Development), Service (Sequence Analysis Platform, Molecular Modelling, Clinical Trial Data Management, Docking, and Others), Solutions (Software and Services), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Others)
The South and Central America Drug Discovery Informatics Market is poised for significant growth, projected to reach approximately US$ 594.4 million by 2031, up from US$ 252.0 million in 2024. This growth trajectory indicates a robust compound annual growth rate (CAGR) of 13.4% from 2025 to 2031, reflecting the increasing importance of informatics in drug discovery processes across the region.
Executive Summary
Currently, the drug discovery informatics market in South and Central America is in its nascent stages but is witnessing rapid development, particularly in key countries like Brazil, Argentina, and Chile. Brazil's Ministry of Health has made a substantial investment of R$6 billion in 2023 aimed at digital health transformation, which includes enhancing bioinformatics capabilities at Fiocruz, the largest public health research institution in Latin America. In Argentina, the National Scientific and Technical Research Council has reported a remarkable 150% increase in publications related to computational biology since 2018, indicating a growing academic interest in this field. Additionally, Chile's Corfo innovation agency has supported 15 AI-health startups through its TechHealth program, further highlighting the region's commitment to advancing health informatics.
Despite these advancements, the region faces several challenges. Internet infrastructure remains inconsistent, with only 65% of the population having reliable broadband access, which can hinder the growth of digital health initiatives. Furthermore, there is a limited availability of venture capital for health technology startups, which can restrict innovation and development in the sector. However, recent collaborations between Brazilian research institutions and European pharmaceutical companies signal a growing international interest in the region's informatics capabilities, particularly for research focused on tropical diseases.
Market Segmentation Analysis
The South and Central America Drug Discovery Informatics Market can be segmented based on various criteria:
The advent of cloud computing is revolutionizing the drug discovery informatics landscape. Cloud solutions provide unparalleled advantages in data storage, processing power, and accessibility, allowing organizations to manage vast datasets essential for modern drug discovery without the need for heavy investments in on-premises infrastructure. These platforms enable real-time data access and facilitate collaboration among global teams, thereby accelerating innovation cycles and reducing time to market.
Cloud computing supports the integration of diverse data types, from genomic sequences to clinical trial results, enabling comprehensive analysis and quicker decision-making. The pay-as-you-go pricing models associated with cloud services lower entry barriers for smaller firms and academic labs, democratizing access to advanced informatics capabilities. Additionally, cloud providers continuously enhance their platforms with the latest security protocols, compliance certifications, and cutting-edge AI/ML tools, alleviating the operational burden on organizations and ensuring they benefit from state-of-the-art technology.
Country Insights
In terms of geographical segmentation, Brazil, Argentina, and the Rest of South and Central America are the primary markets. Brazil, being the largest pharmaceutical market in South America, plays a crucial role in driving the drug discovery informatics market. The country's robust domestic pharmaceutical industry, combined with its large and diverse population, positions it as an attractive hub for clinical trials and research and development activities. The Brazilian government significantly supports biomedical research through its publicly funded healthcare system (SUS) and various research foundations, creating a demand for informatics solutions to manage and analyze complex data.
The increasing prevalence of chronic diseases and a growing focus on biopharmaceuticals and biosimilars further fuel market growth. The Brazilian government’s substantial investment in healthcare, which accounts for approximately 10% of the country's GDP, underscores the importance of informatics in enhancing healthcare delivery and drug development.
Company Profiles
Key players in the Drug Discovery Informatics Market include Dassault Syst?mes SE, Eurofins Scientific SE, Charles River Laboratories International Inc, Jubilant Pharma Limited, Revvity Inc, Thermo Fisher Scientific Inc., Certera, Selvita, Collaborative Drug Discovery, Inc., and Illumina, Inc. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their clients.
Executive Summary
Currently, the drug discovery informatics market in South and Central America is in its nascent stages but is witnessing rapid development, particularly in key countries like Brazil, Argentina, and Chile. Brazil's Ministry of Health has made a substantial investment of R$6 billion in 2023 aimed at digital health transformation, which includes enhancing bioinformatics capabilities at Fiocruz, the largest public health research institution in Latin America. In Argentina, the National Scientific and Technical Research Council has reported a remarkable 150% increase in publications related to computational biology since 2018, indicating a growing academic interest in this field. Additionally, Chile's Corfo innovation agency has supported 15 AI-health startups through its TechHealth program, further highlighting the region's commitment to advancing health informatics.
Despite these advancements, the region faces several challenges. Internet infrastructure remains inconsistent, with only 65% of the population having reliable broadband access, which can hinder the growth of digital health initiatives. Furthermore, there is a limited availability of venture capital for health technology startups, which can restrict innovation and development in the sector. However, recent collaborations between Brazilian research institutions and European pharmaceutical companies signal a growing international interest in the region's informatics capabilities, particularly for research focused on tropical diseases.
Market Segmentation Analysis
The South and Central America Drug Discovery Informatics Market can be segmented based on various criteria:
- By Workflow: The market is divided into Discovery Informatics and Drug Development, with the Discovery Informatics segment leading the market in 2024.
- By Service: Key services include Sequence Analysis Platform, Molecular Modelling, Clinical Trial Data Management, Docking, and others, with the Sequence Analysis Platform being the dominant service in 2024.
- By Solutions: The market is categorized into Software and Services, where the Software segment holds the largest share.
- By End User: The primary end users are Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and others, with Pharmaceutical and Biotechnology Companies being the leading segment.
The advent of cloud computing is revolutionizing the drug discovery informatics landscape. Cloud solutions provide unparalleled advantages in data storage, processing power, and accessibility, allowing organizations to manage vast datasets essential for modern drug discovery without the need for heavy investments in on-premises infrastructure. These platforms enable real-time data access and facilitate collaboration among global teams, thereby accelerating innovation cycles and reducing time to market.
Cloud computing supports the integration of diverse data types, from genomic sequences to clinical trial results, enabling comprehensive analysis and quicker decision-making. The pay-as-you-go pricing models associated with cloud services lower entry barriers for smaller firms and academic labs, democratizing access to advanced informatics capabilities. Additionally, cloud providers continuously enhance their platforms with the latest security protocols, compliance certifications, and cutting-edge AI/ML tools, alleviating the operational burden on organizations and ensuring they benefit from state-of-the-art technology.
Country Insights
In terms of geographical segmentation, Brazil, Argentina, and the Rest of South and Central America are the primary markets. Brazil, being the largest pharmaceutical market in South America, plays a crucial role in driving the drug discovery informatics market. The country's robust domestic pharmaceutical industry, combined with its large and diverse population, positions it as an attractive hub for clinical trials and research and development activities. The Brazilian government significantly supports biomedical research through its publicly funded healthcare system (SUS) and various research foundations, creating a demand for informatics solutions to manage and analyze complex data.
The increasing prevalence of chronic diseases and a growing focus on biopharmaceuticals and biosimilars further fuel market growth. The Brazilian government’s substantial investment in healthcare, which accounts for approximately 10% of the country's GDP, underscores the importance of informatics in enhancing healthcare delivery and drug development.
Company Profiles
Key players in the Drug Discovery Informatics Market include Dassault Syst?mes SE, Eurofins Scientific SE, Charles River Laboratories International Inc, Jubilant Pharma Limited, Revvity Inc, Thermo Fisher Scientific Inc., Certera, Selvita, Collaborative Drug Discovery, Inc., and Illumina, Inc. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their clients.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DRUG DISCOVERY INFORMATICS MARKET LANDSCAPE
4.1 Market Overview
4.2 PESTAnalysis
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors or Suppliers
4.3.4 End-Use Industry
4.3.5 List of Vendors in the Value Chain
5. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DRUG DISCOVERY INFORMATICS MARKET - SOUTH AND CENTRAL AMERICA MARKET ANALYSIS
6.1 South and Central America Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
6.2 South and Central America Drug Discovery Informatics Market Forecast and Analysis
7. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY WORKFLOW
7.1 Discovery Informatics
7.1.1 Overview
7.1.2 Discovery Informatics: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Drug Development
7.2.1 Overview
7.2.2 Drug Development: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SERVICE
8.1 Sequence Analysis Platform
8.1.1 Overview
8.1.2 Sequence Analysis Platform: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Molecular Modelling
8.2.1 Overview
8.2.2 Molecular Modelling: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Clinical Trial Data Management
8.3.1 Overview
8.3.2 Clinical Trial Data Management: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Docking
8.4.1 Overview
8.4.2 Docking: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SOLUTIONS
9.1 Software
9.1.1 Overview
9.1.2 Software: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Services
9.2.1 Overview
9.2.2 Services: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Contract Research Organizations (CROs)
10.2.1 Overview
10.2.2 Contract Research Organizations (CROs): South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET - COUNTRY ANALYSIS
11.1 South and Central America
11.1.1 South and Central America Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.1.1 South and Central America Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Brazil: South and Central America Drug Discovery Informatics Market Share - by Workflow
11.1.2.2.2 Brazil: South and Central America Drug Discovery Informatics Market Share - by Service
11.1.2.2.3 Brazil: South and Central America Drug Discovery Informatics Market Share - by Solutions
11.1.2.2.4 Brazil: South and Central America Drug Discovery Informatics Market Share - by End User
11.2.3.3 Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Argentina: South and Central America Drug Discovery Informatics Market Share - by Workflow
11.2.3.3.2 Argentina: South and Central America Drug Discovery Informatics Market Share - by Service
11.2.3.3.3 Argentina: South and Central America Drug Discovery Informatics Market Share - by Solutions
11.2.3.3.4 Argentina: South and Central America Drug Discovery Informatics Market Share - by End User
11.3.4.4 Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by Workflow
11.3.4.4.2 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by Service
11.3.4.4.3 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by Solutions
11.3.4.4.4 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by End User
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Dassault Systemes SE
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eurofins Scientific SE
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Jubilant Pharma Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Revvity Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Certera
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Selvita
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Collaborative Drug Discovery, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Illumina, Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DRUG DISCOVERY INFORMATICS MARKET LANDSCAPE
4.1 Market Overview
4.2 PESTAnalysis
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors or Suppliers
4.3.4 End-Use Industry
4.3.5 List of Vendors in the Value Chain
5. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DRUG DISCOVERY INFORMATICS MARKET - SOUTH AND CENTRAL AMERICA MARKET ANALYSIS
6.1 South and Central America Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
6.2 South and Central America Drug Discovery Informatics Market Forecast and Analysis
7. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY WORKFLOW
7.1 Discovery Informatics
7.1.1 Overview
7.1.2 Discovery Informatics: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Drug Development
7.2.1 Overview
7.2.2 Drug Development: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SERVICE
8.1 Sequence Analysis Platform
8.1.1 Overview
8.1.2 Sequence Analysis Platform: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Molecular Modelling
8.2.1 Overview
8.2.2 Molecular Modelling: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Clinical Trial Data Management
8.3.1 Overview
8.3.2 Clinical Trial Data Management: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Docking
8.4.1 Overview
8.4.2 Docking: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SOLUTIONS
9.1 Software
9.1.1 Overview
9.1.2 Software: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Services
9.2.1 Overview
9.2.2 Services: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Contract Research Organizations (CROs)
10.2.1 Overview
10.2.2 Contract Research Organizations (CROs): South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. SOUTH AND CENTRAL AMERICA DRUG DISCOVERY INFORMATICS MARKET - COUNTRY ANALYSIS
11.1 South and Central America
11.1.1 South and Central America Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.1.1 South and Central America Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Brazil: South and Central America Drug Discovery Informatics Market Share - by Workflow
11.1.2.2.2 Brazil: South and Central America Drug Discovery Informatics Market Share - by Service
11.1.2.2.3 Brazil: South and Central America Drug Discovery Informatics Market Share - by Solutions
11.1.2.2.4 Brazil: South and Central America Drug Discovery Informatics Market Share - by End User
11.2.3.3 Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Argentina: South and Central America Drug Discovery Informatics Market Share - by Workflow
11.2.3.3.2 Argentina: South and Central America Drug Discovery Informatics Market Share - by Service
11.2.3.3.3 Argentina: South and Central America Drug Discovery Informatics Market Share - by Solutions
11.2.3.3.4 Argentina: South and Central America Drug Discovery Informatics Market Share - by End User
11.3.4.4 Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by Workflow
11.3.4.4.2 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by Service
11.3.4.4.3 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by Solutions
11.3.4.4.4 Rest of South and Central America: South and Central America Drug Discovery Informatics Market Share - by End User
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Dassault Systemes SE
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eurofins Scientific SE
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Jubilant Pharma Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Revvity Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Certera
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Selvita
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Collaborative Drug Discovery, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Illumina, Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
LIST OF TABLES
Table 1. South and Central America Drug Discovery Informatics Market Segmentation
Table 2. List of Vendors
Table 3. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 5. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 6. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 7. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 10. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 11. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 12. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 14. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 15. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 16. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 18. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 19. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 20. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Heat Map Analysis by Key Players
Table 1. South and Central America Drug Discovery Informatics Market Segmentation
Table 2. List of Vendors
Table 3. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 5. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 6. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 7. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 10. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 11. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 12. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 14. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 15. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 16. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 18. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 19. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 20. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. South and Central America Drug Discovery Informatics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Drug Discovery Informatics Market
Figure 4. South and Central America Drug Discovery Informatics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South and Central America Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
Figure 7. South and Central America Drug Discovery Informatics Market Share (%) - by Workflow, 2024 and 2031
Figure 8. Discovery Informatics: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Drug Development: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. South and Central America Drug Discovery Informatics Market Share (%) - by Service, 2024 and 2031
Figure 11. Sequence Analysis Platform: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Molecular Modelling: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Clinical Trial Data Management: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Docking: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. South and Central America Drug Discovery Informatics Market Share (%) - by Solutions, 2024 and 2031
Figure 17. Software: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Services: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. South and Central America Drug Discovery Informatics Market Share (%) - by End User, 2024 and 2031
Figure 20. Pharmaceutical and Biotechnology Companies: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Contract Research Organizations (CROs): South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South and Central America Drug Discovery Informatics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 24. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Company Positioning & Concentration
Figure 1. South and Central America Drug Discovery Informatics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Drug Discovery Informatics Market
Figure 4. South and Central America Drug Discovery Informatics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South and Central America Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
Figure 7. South and Central America Drug Discovery Informatics Market Share (%) - by Workflow, 2024 and 2031
Figure 8. Discovery Informatics: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Drug Development: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. South and Central America Drug Discovery Informatics Market Share (%) - by Service, 2024 and 2031
Figure 11. Sequence Analysis Platform: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Molecular Modelling: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Clinical Trial Data Management: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Docking: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. South and Central America Drug Discovery Informatics Market Share (%) - by Solutions, 2024 and 2031
Figure 17. Software: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Services: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. South and Central America Drug Discovery Informatics Market Share (%) - by End User, 2024 and 2031
Figure 20. Pharmaceutical and Biotechnology Companies: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Contract Research Organizations (CROs): South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Others: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South and Central America Drug Discovery Informatics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 24. Brazil: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Argentina: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Rest of South and Central America: South and Central America Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Company Positioning & Concentration
